Navigation Links
AACR & IASLC to host molecular origins of lung cancer conference
Date:12/15/2011

What:

The second AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine will bring together scientists to share the latest findings in the diagnosis, treatment and prevention of the nation's leading cause of cancer and cancer mortality.

The conference, scheduled for Jan. 8-11, 2012, in San Diego, is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

The conference will feature a series of groundbreaking oral presentations and hundreds of abstracts including:

  • prevention of tobacco damage using antiestrogens;
  • the role of tumor suppressor genes in small cell lung cancer;
  • a phase 2 study of sorafenib in patients with stage IV disease;
  • new tools to measure circulating tumor cells;
  • new data on microRNA and KRAS mutations

When:

Jan. 8-11, 2012

Where: San Diego Marriott Hotel & Marina San Diego, Calif.


'/>"/>
Contact: Natalie Poole
Natalie.Poole@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. AVS 55th International Symposium & Exhibition, Oct. 19-24
2. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
3. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
4. Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding
5. Singapore opens Fusionopolis, its second major R&D hub in 5 years
6. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
7. Texas A&M anthropologist discovers long-lost primate in Indonesia
8. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
9. Ancestral genome of present-day African great apes & humans had burst of DNA sequence duplication
10. NTU seals global partnerships on environmental sciences R&D
11. UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... ... May 26, 2016 , ... ... today announced several positive developments that position the Company for the future. ... the transaction, Craig F. Kinghorn has been appointed Chairman of the Board, Curtis ...
(Date:5/25/2016)... ... May 25, 2016 , ... Founder ... double board-certified in surgery and surgery of the hand by the National Board ... stranger to going above and beyond in his pursuit of providing the most ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Drug Administration (FDA) has granted the company’s orphan drug designation request covering BHV-4157 ... drug designation granted by the FDA. , Spinocerebellar ataxia is a rare, ...
(Date:5/23/2016)... , ... May 23, 2016 , ... The need for blood donations in South Texas ... by the South Texas Blood & Tissue Center, blood donations are on the decline. In ... and they are down 21 percent in South Texas in the last four years alone. ...
Breaking Biology Technology: